- Drug developed for lung disease may slow biological aging in surprising ‘bonus’ Fox News
- Early Data Indicates an A.I.-Generated Drug Could Slow Aging The New York Times
- Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment Nature
- Insilico's IPF candidate rentosertib shows anti-aging promise FirstWord Pharma
- AI-designed drug candidate reverses biological age in clinical study News-Medical
Рекомендовані коментарі
Для публікації повідомлень створіть обліковий запис або авторизуйтесь